The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci164185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Shun-Mei Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Hypothalamus, Neurons. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Glucose homeostasis can be improved after bariatric surgery, which alters bile flow and stimulates gut hormone secretion, particularly FGF15/19. FGFR1 expression in AGRP-expressing cells is required for bile acids' ability to improve glucose control. We show that the mouse Agrp gene has 3 promoter/enhancer regions that direct transcription of each of their own AGRP transcripts. One of these Agrp promoters/enhancers, Agrp-B, is regulated by bile acids. We generated an Agrp-B knockin FLP/knockout allele. AGRP-B-expressing cells are found in endocrine cells of the pars tuberalis and coexpress diacylglycerol lipase B - an endocannabinoid biosynthetic enzyme - distinct from pars tuberalis thyrotropes. AGRP-B expression is also found in the folliculostellate cells of the pituitary's anterior lobe. Mice without AGRP-B were protected from glucose intolerance induced by high-fat feeding but not from excess weight gain. Chemogenetic inhibition of AGRP-B cells improved glucose tolerance by enhancing glucose-stimulated insulin secretion. Inhibition of the AGRP-B cells also caused weight loss. The improved glucose tolerance and reduced body weight persisted up to 6 weeks after cessation of the DREADD-mediated inhibition, suggesting the presence of a biological switch for glucose homeostasis that is regulated by long-term stability of food availability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine.
- Department of Neuroscience, and.
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, New York, USA.
Förderung
- NICHD NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- NIH
Zitieren
APA
Liu, S. M., Ifebi, B., Johnson, F., Xu, A., Ho, J., Yang, Y., Schwartz, G., Jo, Y. H., & Chua, S. (2023). The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis. Journal of Clinical Investigation. https://doi.org/10.1172/jci164185
Vancouver
Liu SM, Ifebi B, Johnson F, Xu A, Ho J, Yang Y, et al. The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis. Journal of Clinical Investigation. 2023. doi:10.1172/jci164185
BibTeX
@article{Liu2023,
author = {Liu, Shun-Mei and Ifebi, Bruno and Johnson, Fred and Xu, Alison and Ho, Jacquelin and Yang, Yunlei and Schwartz, Gary and Jo, Young Hwan and Chua, Streamson},
title = {The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci164185}
}
EUVIMED